3/5/2013

Medical societies including SCAI have issued an appropriate-use criteria document for the use of implantable cardioverter defibrillators and cardiac resynchronization therapy. The document covers 369 clinical scenarios and describes a number of indications that aren't reimbursed by Medicare as appropriate.

Related Summaries